Clinical Trial Update: Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trials evaluating naltrexone implants to prevent relapse after inpatient treatment for opioid dependence have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Naltrexone implants (naltrexone)

Snippet

Sponsor: University of Oslo | Conditions: Opiate Dependence | Phase 2, Phase 3 | Status: COMPLETED